Rockville, Md., December 6, 2007 The U.S. Pharmacopeia (USP) has formed a strategic alliance with Quantros, a health care information management technology provider, to enhance MEDMARX, USPs premier adverse drug event reporting program. The more robust database resulting from this alliance will provide USP and users of MEDMARX access to larger data sets from more U.S. hospitals and health systems for the identification and prevention of medication errors and adverse drug events. The MEDMARX database currently draws from more than 400 hospitals and healthcare systems and is the largest medication error database in the world.
Under this arrangement, Quantros will manage the operations of the MEDMARX system, including marketing, sales and client support. This will enable USP to continue its focus, even more intently, on data analysis, research, standards-setting and dissemination of safe practices that will help practitioners prevent errors.
Quantros and USPs patient safety efforts are complementary, said Roger L. Williams, M.D., executive vice president and CEO of USP. The two organizations share a commitment to reducing medication errors and improving public health. This partnership will provide customers with the best of each organizations strengthsclinical technology management from Quantros, and data analysis, research, standards-setting and reporting from USP.
We look forward to providing MEDMARX subscribers with an even more robust database that can reveal to health care providers additional valuable patient safety information, said Sanjaya Kumar, M.D., president and CEO of Quantros.
The USP/Quantros partnership takes effect Jan. 1, 2008.
|Contact: Sandra Kim|